Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 8Colonic Neoplasms 5Motor Activity 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Weight Loss 1Urologic Neoplasms 1Smoking Cessation 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Polyps 1Patient Compliance 1Pancreatitis, Chronic 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Duodenal Neoplasms 1Diabetes Mellitus, Type 2 1Colorectal Cancer Prevention 1Cholangiocarcinoma 1Breast Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Diet × Gastrointestinal × Clear all
NCT03410641 2018-01-25

Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study

Oslo University Hospital

Completed
1,216 enrolled
GastrointestinalGenitourinaryThoracic

Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Urologic Neoplasms, Weight Loss, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡